Carvell Industries has gathered the following information about the actual sales revenues and expenses for its pharmaceuticals segment for the most recent year. (Click the icon to view the actual data.) Budgeted data for the same time period for the pharmaceutical segment are as follows (all data are in millions): Prepare a segment margin performance report for the pharmaceutical segment. Calculate a variance and a variance percentage for each line in the report. Round to the nearest hundredth for the variance percentages (for example, if your answer is 16.2384%, round it to 16.24%). Begin by preparing the performance report through the contribution margin line. Next, complete the report through the segment margin line, and then, finally, complete the report through the operating income line. (Enter the variances as positive numbers. Round the variance percentages to the nearest hundredth percent, XXX%.) Performance Report Carvell - Pharmaceutical Segment For Fiscal Year Ending December 31 Data table - Sales Less Variable Expenses: Variable Cost of Goods Sold Variable Operating Expenses Contribution Margin Less Direct Fixed Expenses: Fixed Manufacturing Overhead Fixed Operating Expenses Segment Margin Less Common Fixed Expenses allocated to the profit center: Actual Bugeted Budgeted sales in units. 9,100 Variance Variance % Budgeted average selling price per unit $ 80 % Variable Cost of Goods Sold per unit. $ 24 Variable Operating Expenses per unit. $ 10 % Direct Fixed Manufacturing Overhead (in total) $ 90,000 % Direct Fixed Operating Expenses (in total) $ 20,000 % Common Fixed Expenses Allocated to the Pharmaceutical Segment $ 15,000 % Data table % % % - Sales $ 771,680 Variable Cost of Goods Sold $ 235,872 Variable Operating Expenses $ 85,540 Direct Fixed Manufacturing Overhead $ 94,500 st Direct Fixed Operating Expenses $ 21,800